Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.
FDA Approvals
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.
Leave a Reply